US Patent Issued to Actelion Pharmaceuticals on Sept. 23 for "Transitioning patients treated for pulmonary arterial hypertension to selexipag" (New Jersey, North Carolina, California Inventors)

ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,419,887, issued on Sept. 23, was assigned to Actelion Pharmaceuticals Ltd. (Allschwil, Switzerland).

"Transitioning patients treated for pulmonary arterial hypertension to selexipag" was invented by Carol Zhao (Titusville, N.J.), Johanna Colvin Riesen (Titusville, N.J.), Gary Arnold Palmer (Titusville, N.J.), Michael Keating (Fairview, N.C.), Brian Hartline (San Diego), Wade Benton (Redwood City, Calif.), Camelia Dumitrescu (San Francisco) and Mehul Bipinchandra Shah (Titusville, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides methods of transitioning a patient being treated for pulmonary arterial hypertension with a...